9914 related articles for article (PubMed ID: 12910630)
1. [Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression].
Capuron L; Dantzer R; Miller AH
J Soc Biol; 2003; 197(2):151-6. PubMed ID: 12910630
[TBL] [Abstract][Full Text] [Related]
2. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
Capuron L; Ravaud A; Miller AH; Dantzer R
Brain Behav Immun; 2004 May; 18(3):205-13. PubMed ID: 15050647
[TBL] [Abstract][Full Text] [Related]
3. Cytokines and psychopathology: lessons from interferon-alpha.
Capuron L; Miller AH
Biol Psychiatry; 2004 Dec; 56(11):819-24. PubMed ID: 15576057
[TBL] [Abstract][Full Text] [Related]
4. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
[TBL] [Abstract][Full Text] [Related]
5. Administration of interferon-alpha in mice provokes peripheral and central modulation of immune cells, accompanied by behavioral effects.
Orsal AS; Blois SM; Bermpohl D; Schaefer M; Coquery N
Neuropsychobiology; 2008; 58(3-4):211-22. PubMed ID: 19212136
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
Hauser P
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
[TBL] [Abstract][Full Text] [Related]
7. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C.
Amodio P; De Toni EN; Cavalletto L; Mapelli D; Bernardinello E; Del Piccolo F; Bergamelli C; Costanzo R; Bergamaschi F; Poma SZ; Chemello L; Gatta A; Perini G
J Affect Disord; 2005 Jan; 84(1):93-8. PubMed ID: 15620390
[TBL] [Abstract][Full Text] [Related]
8. Mood and cognitive side effects of interferon-alpha therapy.
Valentine AD; Meyers CA; Kling MA; Richelson E; Hauser P
Semin Oncol; 1998 Feb; 25(1 Suppl 1):39-47. PubMed ID: 9482539
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.
Licinio J; Kling MA; Hauser P
Semin Oncol; 1998 Feb; 25(1 Suppl 1):30-8. PubMed ID: 9482538
[TBL] [Abstract][Full Text] [Related]
10. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
11. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
[TBL] [Abstract][Full Text] [Related]
12. Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.
Galvão-de Almeida A; Guindalini C; Batista-Neves S; de Oliveira IR; Miranda-Scippa A; Quarantini LC
Gen Hosp Psychiatry; 2010; 32(4):401-5. PubMed ID: 20633744
[TBL] [Abstract][Full Text] [Related]
13. [Incidence, pathoetiology and treatment of interferon-alpha induced neuro-psychiatric side effects].
Schäfer M; Schwaiger M
Fortschr Neurol Psychiatr; 2003 Sep; 71(9):469-76. PubMed ID: 12975732
[TBL] [Abstract][Full Text] [Related]
14. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.
Wichers MC; Maes M
J Psychiatry Neurosci; 2004 Jan; 29(1):11-7. PubMed ID: 14719046
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol.
Wichers MC; Kenis G; Koek GH; Robaeys G; Nicolson NA; Maes M
J Psychosom Res; 2007 Feb; 62(2):207-14. PubMed ID: 17270579
[TBL] [Abstract][Full Text] [Related]
16. Interferon-induced depression in chronic hepatitis C.
Horsmans Y
J Antimicrob Chemother; 2006 Oct; 58(4):711-3. PubMed ID: 16951413
[TBL] [Abstract][Full Text] [Related]
17. Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.
Bannink M; Kruit WH; Van Gool AR; Mulder PG; Sleijfer S; Eggermont AM; Stoter G; Fekkes D
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):109-14. PubMed ID: 15610952
[TBL] [Abstract][Full Text] [Related]
18. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Capuron L; Gumnick JF; Musselman DL; Lawson DH; Reemsnyder A; Nemeroff CB; Miller AH
Neuropsychopharmacology; 2002 May; 26(5):643-52. PubMed ID: 11927189
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of interferon-alpha therapy.
Weiss K
Semin Oncol; 1998 Feb; 25(1 Suppl 1):9-13. PubMed ID: 9482535
[TBL] [Abstract][Full Text] [Related]
20. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.
Gold SM; Irwin MR
Neurol Clin; 2006 Aug; 24(3):507-19. PubMed ID: 16877121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
